Maria Helena Vasconcelos

25PUBLICATIONS
106CO-AUTHORS
Medical bacteriologyMedical infection agents (incl. prions)Predictive and prognostic markersMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 13, 2026
Bacterioruberin from Haloferax mediterranei Triggers Cytotoxic and Pro-Oxidant Effects in Different Solid Tumour Models, Effectively Targeting P-gp-Resistant Lung Cancer Cells.

|Jun 25, 2026
A Minimally Invasive, Extracellular Vesicle-Based Approach for Monitoring Measurable Residual Disease in Acute Myeloid Leukemia: A Proof-of-Concept Study.

|Dec 04, 2024
Preclinical studies on the antitumor and non-toxic effect of combining pirfenidone with vinorelbine and carboplatin in non-small cell lung cancer.

Helena Branco, Catarina A Rodrigues, Júlio Oliveira

|Sep 03, 2024
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma.

Sofia M Sousa, Helena Branco, Amir Avan

|Aug 02, 2024
Discovery of Potent Isoquinolinequinone N-Oxides to Overcome Cancer Multidrug Resistance.

Ryan D Kruschel, Mélanie A G Barbosa, Maria João Almeida

|Apr 27, 2024
Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132.

Andreia Palmeira, Emília Sousa, Aylin Köseler

Pageof 5

Frequent Collaborators

14 joint publications

Cristina Pinto Ribeiro Xavier

8 joint publications

Maria Emília Sousa

4 joint publications

Mélanie A G Barbosa

3 joint publications

Raquel T Lima